FXH Quote, Financials, Valuation and Earnings

iShares Biotechnology ETF has a net margin of -- compared to First Trust Health Care AlphaDEX Fund's net margin of --. First Trust Health Care AlphaDEX Fund's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.

First Trust Health Care AlphaDEX Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Health Care AlphaDEX Fund has higher upside potential than iShares Biotechnology ETF, analysts believe First Trust Health Care AlphaDEX Fund is more attractive than iShares Biotechnology ETF.

First Trust Health Care AlphaDEX Fund has a beta of 0.771, which suggesting that the stock is 22.906% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.046%.

First Trust Health Care AlphaDEX Fund has a quarterly dividend of $0.09 per share corresponding to a yield of 0.41%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. First Trust Health Care AlphaDEX Fund pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.

First Trust Health Care AlphaDEX Fund quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. First Trust Health Care AlphaDEX Fund's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, First Trust Health Care AlphaDEX Fund's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Health Care AlphaDEX Fund is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to First Trust Health Care AlphaDEX Fund's net margin of --. First Trust Health Care AlphaDEX Fund's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.

First Trust Health Care AlphaDEX Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Health Care AlphaDEX Fund has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe First Trust Health Care AlphaDEX Fund is more attractive than Invesco Nasdaq Biotechnology ETF.

First Trust Health Care AlphaDEX Fund has a beta of 0.771, which suggesting that the stock is 22.906% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

First Trust Health Care AlphaDEX Fund has a quarterly dividend of $0.09 per share corresponding to a yield of 0.41%. Invesco Nasdaq Biotechnology ETF offers a yield of 1.09% to investors and pays a quarterly dividend of $0.06 per share. First Trust Health Care AlphaDEX Fund pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.

First Trust Health Care AlphaDEX Fund quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. First Trust Health Care AlphaDEX Fund's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, First Trust Health Care AlphaDEX Fund's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Health Care AlphaDEX Fund is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.

iShares US Medical Devices ETF has a net margin of -- compared to First Trust Health Care AlphaDEX Fund's net margin of --. First Trust Health Care AlphaDEX Fund's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.

First Trust Health Care AlphaDEX Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Health Care AlphaDEX Fund has higher upside potential than iShares US Medical Devices ETF, analysts believe First Trust Health Care AlphaDEX Fund is more attractive than iShares US Medical Devices ETF.

First Trust Health Care AlphaDEX Fund has a beta of 0.771, which suggesting that the stock is 22.906% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.904, suggesting its less volatile than the S&P 500 by 9.601%.

First Trust Health Care AlphaDEX Fund has a quarterly dividend of $0.09 per share corresponding to a yield of 0.41%. iShares US Medical Devices ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.11 per share. First Trust Health Care AlphaDEX Fund pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.

First Trust Health Care AlphaDEX Fund quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. First Trust Health Care AlphaDEX Fund's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, First Trust Health Care AlphaDEX Fund's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Health Care AlphaDEX Fund is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.